Original language | English |
---|---|
Pages (from-to) | 710 |
Journal | Blood |
Volume | 144 |
Issue number | Supplement 1 |
DOIs | |
Publication status | Published - 5 Nov 2024 |
A Phase 2 Study of Ianalumab in Patients with Primary Immune Thrombocytopenia Previously Treated with at Least Two Lines of Therapy: Interim Results from VAYHIT3
David J Kuter, Tomas Jose Gonzalez Lopez, Karolin Trautmann-Grill, Mathias J. Rummel, Philip Young-Ill Choi, Alessandra Borchiellini, Muhlis Cem Ar, Huyen Tran, Tienan Zhu, Jae-Ho Yoon, Nichola Cooper, Thomas Stauch, Pinar Tarkun, Fabienne Le Gac, Alex Allepuz, Patrick Urban, Renxin Lin, Charlotte A. Bradbury
Research output: Contribution to journal › Article (Academic Journal) › peer-review